• BIOHEALTH CAPITAL REGION
  • GREATER PHILADELPHIA
  • NORTH CAROLINA
  • MEDIA
    • News + Articles
      • People
      • Real Estate
      • Funding
      • Industry Trends
      • Career & Professional Development
    • Events
      • Events Calendar
      • Submit an Event [for FREE]
  • COMMUNITY
    • Grow Your Professional Network
    • BioHealth Capital Region (MD/DC/VA)
    • Greater Philadelphia (PA/DE/NJ)
    • North Carolina (NC)
  • JOBS
    • Get Hired
    • Jobs
    • Career Resources
  • FOR EMPLOYERS
    • Hire An Expert
    • Services
GET HIRED
HIRE

Humacyte Reports More Positive Results from Engineered Blood Vessels in Ukraine

Published on : September 5, 2024September 5, 2024 Published by : BioBuzz Media

Humacyte Reports More Positive Results from Engineered Blood Vessels in Ukraine By Barry Teater | September 5, 2024 Durham-based Humacyte has presented positive long-term results from its bioengineered blood vessels [….]

Tagged in : ATEV Humacyte Research Triangle Park
Categorized in : Industry Trends Research Triangle Park News

LATEST POSTS

  • People on the Move: Maya Yovcheva Promoted at Thermo Fisher Scientific as Senior Project Manager
  • Unlock Your Future: 2024 Biotechnology and Health Career and Internship Fair at Northwest High School!
  • People on the Move: Robert Lalley, MBA, Director of Gene Therapy Procurement – Site Head, Catalent Pharma Solutions
  • In Conversation with Matthew Stamm, Associate Professor of Electrical and Computer Engineering, Drexel University College of Engineering
  • People on the Move: Dr. Gallia G. Levy Departs Spark Therapeutics to Join Kite as Global Head of Clinical Development

About BioBuzz

Our History

Our Expert Advisors

Our Board of Buzz

Our Ambassadors

  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Terms & Conditions  Privacy Policy
Made with ♥ in Baltimore

© 2023 BioBuzz Media™

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy